YungShin Global Holding Corp (3705) - Net Assets
Based on the latest financial reports, YungShin Global Holding Corp (3705) has net assets worth NT$8.97 Billion TWD (≈ $282.75 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$12.61 Billion ≈ $397.36 Million USD) and total liabilities (NT$3.64 Billion ≈ $114.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 3705 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$8.97 Billion |
| % of Total Assets | 71.16% |
| Annual Growth Rate | 2.62% |
| 5-Year Change | 32.21% |
| 10-Year Change | 49.17% |
| Growth Volatility | 6.12 |
YungShin Global Holding Corp - Net Assets Trend (2000–2025)
This chart illustrates how YungShin Global Holding Corp's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of YungShin Global Holding Corp to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for YungShin Global Holding Corp (2000–2025)
The table below shows the annual net assets of YungShin Global Holding Corp from 2000 to 2025. For live valuation and market cap data, see 3705 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$8.97 Billion ≈ $282.75 Million |
-10.04% |
| 2024-12-31 | NT$9.98 Billion ≈ $314.31 Million |
+26.04% |
| 2023-12-31 | NT$7.91 Billion ≈ $249.36 Million |
+2.75% |
| 2022-12-31 | NT$7.70 Billion ≈ $242.69 Million |
+13.48% |
| 2021-12-31 | NT$6.79 Billion ≈ $213.86 Million |
+3.22% |
| 2020-12-31 | NT$6.58 Billion ≈ $207.19 Million |
+2.45% |
| 2019-12-31 | NT$6.42 Billion ≈ $202.23 Million |
+3.54% |
| 2018-12-31 | NT$6.20 Billion ≈ $195.32 Million |
+2.93% |
| 2017-12-31 | NT$6.02 Billion ≈ $189.75 Million |
+0.11% |
| 2016-12-31 | NT$6.02 Billion ≈ $189.55 Million |
-2.33% |
| 2015-12-31 | NT$6.16 Billion ≈ $194.06 Million |
+4.48% |
| 2014-12-31 | NT$5.90 Billion ≈ $185.74 Million |
+4.48% |
| 2013-12-31 | NT$5.64 Billion ≈ $177.78 Million |
+0.75% |
| 2012-12-31 | NT$5.60 Billion ≈ $176.46 Million |
-2.06% |
| 2011-12-31 | NT$5.72 Billion ≈ $180.17 Million |
+2.69% |
| 2010-12-31 | NT$5.57 Billion ≈ $175.46 Million |
+3.34% |
| 2009-12-31 | NT$5.39 Billion ≈ $169.78 Million |
+1.01% |
| 2008-12-31 | NT$5.34 Billion ≈ $168.09 Million |
+1.12% |
| 2007-12-31 | NT$5.28 Billion ≈ $166.23 Million |
+4.34% |
| 2006-12-31 | NT$5.06 Billion ≈ $159.32 Million |
+1.00% |
| 2005-12-31 | NT$5.01 Billion ≈ $157.74 Million |
0.00% |
| 2004-12-31 | NT$5.01 Billion ≈ $157.74 Million |
+4.71% |
| 2003-12-31 | NT$4.78 Billion ≈ $150.64 Million |
+2.77% |
| 2002-12-31 | NT$4.65 Billion ≈ $146.57 Million |
-1.84% |
| 2001-12-31 | NT$4.74 Billion ≈ $149.32 Million |
+0.92% |
| 2000-12-31 | NT$4.70 Billion ≈ $147.96 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to YungShin Global Holding Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 78.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$2.00 Billion | 24.56% |
| Common Stock | NT$2.66 Billion | 32.66% |
| Other Comprehensive Income | NT$1.38 Billion | 16.90% |
| Other Components | NT$2.11 Billion | 25.89% |
| Total Equity | NT$8.16 Billion | 100.00% |
YungShin Global Holding Corp Competitors by Market Cap
The table below lists competitors of YungShin Global Holding Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guoanda Co Ltd
SHE:300902
|
$477.53 Million |
|
Ege Profil Ticaret ve Sanayi AS
IS:EGPRO
|
$477.77 Million |
|
Longjian Road & Bridge Co Ltd
SHG:600853
|
$477.80 Million |
|
EQV Ventures Acquisition Corp. II
NYSE:EVAC
|
$477.93 Million |
|
Inner Mongolia Xinhua Distribution Group Co.Ltd.
SHG:603230
|
$477.48 Million |
|
Boiron SA
PA:BOI
|
$477.46 Million |
|
Man Industries (India) Limited
NSE:MANINDS
|
$477.39 Million |
|
Jinlong Machinery Electronic
SHE:300032
|
$477.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in YungShin Global Holding Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,969,631,000 to 8,158,691,000, a change of 189,060,000 (2.4%).
- Net income of 880,815,000 contributed positively to equity growth.
- Dividend payments of 860,601,000 reduced retained earnings.
- Other comprehensive income increased equity by 348,238,001.
- Other factors decreased equity by 179,392,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$880.82 Million | +10.8% |
| Dividends Paid | NT$860.60 Million | -10.55% |
| Other Comprehensive Income | NT$348.24 Million | +4.27% |
| Other Changes | NT$-179.39 Million | -2.2% |
| Total Change | NT$- | 2.37% |
Book Value vs Market Value Analysis
This analysis compares YungShin Global Holding Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.00x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.02x to 2.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | NT$18.82 | NT$56.90 | x |
| 2006-12-31 | NT$18.98 | NT$56.90 | x |
| 2008-12-31 | NT$19.56 | NT$56.90 | x |
| 2009-12-31 | NT$19.61 | NT$56.90 | x |
| 2010-12-31 | NT$20.29 | NT$56.90 | x |
| 2011-12-31 | NT$20.82 | NT$56.90 | x |
| 2012-12-31 | NT$20.44 | NT$56.90 | x |
| 2013-12-31 | NT$20.47 | NT$56.90 | x |
| 2014-12-31 | NT$21.36 | NT$56.90 | x |
| 2015-12-31 | NT$22.29 | NT$56.90 | x |
| 2016-12-31 | NT$21.85 | NT$56.90 | x |
| 2017-12-31 | NT$22.08 | NT$56.90 | x |
| 2018-12-31 | NT$22.83 | NT$56.90 | x |
| 2019-12-31 | NT$23.46 | NT$56.90 | x |
| 2020-12-31 | NT$24.03 | NT$56.90 | x |
| 2021-12-31 | NT$24.54 | NT$56.90 | x |
| 2022-12-31 | NT$26.87 | NT$56.90 | x |
| 2023-12-31 | NT$27.56 | NT$56.90 | x |
| 2024-12-31 | NT$29.91 | NT$56.90 | x |
| 2025-12-31 | NT$28.45 | NT$56.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently YungShin Global Holding Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.80%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.52%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.55x
- Recent ROE (10.80%) is below the historical average (10.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 6.36% | 10.36% | 0.51x | 1.21x | NT$-166.73 Million |
| 2001 | 8.32% | 12.18% | 0.50x | 1.36x | NT$-77.11 Million |
| 2002 | 9.73% | 14.25% | 0.50x | 1.37x | NT$-12.77 Million |
| 2003 | 10.45% | 15.62% | 0.49x | 1.37x | NT$21.53 Million |
| 2004 | 14.43% | 18.73% | 0.56x | 1.38x | NT$221.56 Million |
| 2005 | 14.43% | 25.71% | 0.48x | 1.16x | NT$221.56 Million |
| 2006 | 9.31% | 15.89% | 0.51x | 1.15x | NT$-35.02 Million |
| 2007 | 10.81% | 14.94% | 0.56x | 1.29x | NT$41.93 Million |
| 2008 | 2.29% | 12.72% | 0.15x | 1.23x | NT$-403.16 Million |
| 2009 | 10.04% | 12.85% | 0.61x | 1.27x | NT$1.97 Million |
| 2010 | 11.75% | 15.33% | 0.60x | 1.28x | NT$94.48 Million |
| 2011 | 9.99% | 12.31% | 0.62x | 1.32x | NT$-476.70K |
| 2012 | 8.16% | 9.45% | 0.64x | 1.36x | NT$-100.10 Million |
| 2013 | 11.35% | 12.23% | 0.62x | 1.51x | NT$73.55 Million |
| 2014 | 12.65% | 12.36% | 0.67x | 1.53x | NT$151.03 Million |
| 2015 | 15.04% | 14.80% | 0.65x | 1.56x | NT$299.34 Million |
| 2016 | 11.31% | 10.63% | 0.61x | 1.75x | NT$75.96 Million |
| 2017 | 8.74% | 7.76% | 0.60x | 1.87x | NT$-74.19 Million |
| 2018 | 11.54% | 9.34% | 0.64x | 1.93x | NT$93.61 Million |
| 2019 | 11.98% | 9.14% | 0.66x | 1.98x | NT$123.59 Million |
| 2020 | 12.36% | 9.79% | 0.64x | 1.97x | NT$151.39 Million |
| 2021 | 11.27% | 9.44% | 0.65x | 1.84x | NT$82.83 Million |
| 2022 | 11.72% | 11.48% | 0.62x | 1.66x | NT$123.05 Million |
| 2023 | 11.27% | 11.77% | 0.61x | 1.57x | NT$93.04 Million |
| 2024 | 14.66% | 14.55% | 0.58x | 1.73x | NT$371.54 Million |
| 2025 | 10.80% | 10.52% | 0.66x | 1.55x | NT$64.95 Million |
Industry Comparison
This section compares YungShin Global Holding Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $3,994,276,111
- Average return on equity (ROE) among peers: 2.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| YungShin Global Holding Corp (3705) | NT$8.97 Billion | 6.36% | 0.41x | $477.50 Million |
| Grape King Bio Ltd (1707) | $1.48 Billion | 1.92% | 0.56x | $465.31 Million |
| Standard Chemical & Pharmaceutical Co Ltd (1720) | $3.31 Billion | 8.21% | 0.55x | $354.12 Million |
| Maywufa Co Ltd (1731) | $1.72 Billion | 4.41% | 0.55x | $91.29 Million |
| ScinoPharm Taiwan Ltd (1789) | $10.23 Billion | 6.44% | 0.25x | $511.95 Million |
| Lotus Pharmaceutical Co Ltd (1795) | $8.73 Billion | 1.19% | 0.78x | $1.60 Billion |
| GeneFerm Biotechnology Co Ltd (1796) | $788.18 Million | -2.86% | 0.45x | $44.41 Million |
| LIWANLI Innovation Co Ltd (3054) | $1.09 Billion | -9.49% | 0.52x | $172.02 Million |
| TTY Biopharm Co Ltd (4105) | $6.23 Billion | 17.56% | 0.54x | $575.79 Million |
| Phytohealth Corp (4108) | $2.37 Billion | -3.10% | 0.03x | $75.09 Million |
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more